Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Bionest Partners and Scisive Consulting Merge to Create "Best in Class" Global Life Sciences Consulting Firm



  Bionest Partners and Scisive Consulting Merge to Create "Best in Class"
  Global Life Sciences Consulting Firm

Business Wire

NEW YORK & PARIS -- January 28, 2013

Bionest Partners Inc. and Scisive Consulting LP, strategy and management
consulting firms for the life science industries, announce their merger today.
The merged companies will operate under the name of Bionest Partners with
offices in New York, Paris, London and San Diego, with presence in Munich and
Tokyo.

Success in today’s competitively evolved medical industry requires insightful
strategy informed by operating practicalities. Bionest Partners has combined
with Scisive Consulting to create a new model consulting firm intensely
responsive to, and highly qualified for, the planning needs of a new
generation of medical business leaders and investors. This fusion of two
highly-respected medical business consultancies equips us to deal with the new
demands of the medical marketplace, and also enables each to augment its
intellectual capital and expand its geographic coverage.

Bionest Partners’ new senior management team will be Alain J. Gilbert and Bob
J. Easton, as Co-Chair, together with partners Dr. Mary Koto, Catharine
Staughton, Olivier Lesueur and Dr. Sean Hu, offering:

  * Complementarity of leadership, at once Strategic with Bob J. Easton and
    Operational with Alain J. Gilbert, to guarantee our clients "Practical
    Operability" of our recommendations
  * Broader sector and deeper functional expertise: drugs/devices/diagnostics
    (including personalized medicine);
    research/development/marketing/planning/pricing/corporate development
  * Personalized Medicine Strategy,  widely  recognized consulting expertise
  * Geographic reach,  with offices in Paris, London, New York, San Diego and
    affiliates in Munich and Tokyo

Bionest Partners Inc. is a Paris and New York-based life sciences business
consulting firm founded in 2003 and led by Alain J. Gilbert. Gilbert has
substantial senior executive experience in life sciences with large and small
companies such as Abbott Diagnostics & Pharmaceuticals, former head of
Medtronic Europe, founder of Idexx in Europe and last founded and spearheaded
the very successful Biogen Europe implantation. Bionest’s leaders include
Olivier Lesueur and Dr. Sean Hu, both with substantial consulting experience:
Olivier with Celerant and Sean with A.T. Kearney and IMS.

Scisive Consulting LP was founded 2008 by Easton and his partners Dr. Mary
Koto and Catharine Staughton. Easton had previously co-founded and served as
President of The Wilkerson Group, the first sizable medical business
consultancy, where Mary and Catharine also had senior roles, and he also
founded and chaired Easton Associates. He has been recognized as one of the
preeminent thought leaders in the global industry. In addition to their
extensive consulting experience, Mary has a history of senior operating roles
in biomedical companies, and Catharine’s career includes securities analysis
and corporate licensing in the pharma space.

About Bionest Partners Inc. & Scisive Consulting LP

Bionest Partners Inc. provides strategy consulting services exclusively for
the life science industries to help pharmaceutical, biopharmaceutical,
diagnostics, biotechnology, and medical device companies, and their
shareholders, maximize the value of their assets and investments. The company,
founded in 2003, has a broad client base with over 100 clients ranging from
large established companies to biotech start-ups and private equity firms,
such as Pfizer, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Novartis,
Johnson & Johnson, Bayer, Biogen Idec, Millennium, AstraZeneca/MedImmune,
Idenix, Stallergenes, Innate Pharma, Genfit, Jubilant, Sequenom, Axa Private
Equity, Blackstone, Candover, Sumitomo, Ipsen, Abbott, Merck, Becton
Dickinson, Cepheid, CareFusion.

The new company focuses on providing actionable strategies through its
expertise in management consulting, including corporate, franchise, portfolio
and product commercialization, organizational and marketing strategies, due
diligence, surrogate management, as well as entry into European and US
markets. New Bionest Partners will be headquartered in New York and maintain
operations in Paris, London and San Diego, and a global network of consultants
and associate members deployed to address specific client assignments and
geographical markets in the Americas, Europe, and Asia Pacific.

Contact:

Bionest Partners Inc.
Robert J. [Bob] Easton
Co-Chairman
Phone: +1 646 619 8717
Mobile: +1 347 524 8392
reaston@bionest.com
www.bionest.com
or
Alain J. Gilbert
Co-Chairman
Phone: +33 1 58 05 14 01
Mobile: + 33 6 07 03 04 84
alain@bionest.com
or
Media Inquiries:
Zimmons International Communications, Inc.
Jennifer K. Zimmons, Ph.D.
Phone: +1 917 214 3514
jzimmons@zimmonsic.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement